To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s ...
The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval.
Moderna Inc.’s shares fell after US regulators refused to review its novel mRNA flu vaccine, creating regulatory chaos for ...
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results